NSTG NanoString Technologies, Inc. Stock Quote

NSTG [NASD]

Index	-	P/E	-	EPS (ttm)	-1.66	Insider Own	0.60%	Shs Outstand	44.07M	Perf Week	7.73%
Market Cap	3.14B	Forward P/E	-	EPS next Y	-2.13	Insider Trans	-36.65%	Shs Float	43.82M	Perf Month	1.95%
Income	-63.10M	PEG	-	EPS next Q	-0.51	Inst Own	97.10%	Short Float	7.91%	Perf Quarter	79.74%
Sales	118.00M	P/S	26.59	EPS this Y	57.60%	Inst Trans	0.12%	Short Ratio	5.12	Perf Half Y	89.65%
Book/sh	2.69	P/B	26.42	EPS next Y	22.50%	ROA	-19.40%	Target Price	65.50	Perf Year	130.42%
Cash/sh	5.23	P/C	13.58	EPS next 5Y	-	ROE	-55.30%	52W Range	13.85 - 78.68	Perf YTD	6.25%
Dividend	-	P/FCF	-	EPS past 5Y	15.90%	ROI	-18.50%	52W High	-9.68%	Beta	1.78
Dividend %	-	Quick Ratio	8.10	Sales past 5Y	21.40%	Gross Margin	57.20%	52W Low	413.07%	ATR	5.01
Employees	551	Current Ratio	8.90	Sales Q/Q	3.90%	Oper. Margin	-42.40%	RSI (14)	59.74	Volatility	8.12% 7.07%
Optionable	Yes	Debt/Eq	1.66	EPS Q/Q	12.50%	Profit Margin	-53.50%	Rel Volume	1.17	Prev Close	72.83
Shortable	Yes	LT Debt/Eq	1.66	Earnings	Nov 09 AMC	Payout	-	Avg Volume	676.79K	Price	71.06
Recom	1.80	SMA20	3.14%	SMA50	21.68%	SMA200	73.52%	Volume	788,715	Change	-2.43%

Jan-06-21

Upgrade

Cowen

Market Perform → Outperform

$75

Sep-09-20

Initiated

Morgan Stanley

Equal-Weight

$43

Nov-15-19

Initiated

Stifel

Buy

Oct-09-18

Initiated

UBS

Buy

Oct-12-17

Downgrade

Janney

Buy → Neutral

Apr-20-17

Downgrade

Morgan Stanley

Overweight → Equal-Weight

Dec-11-13

Upgrade

Robert W. Baird

Neutral → Outperform

$12 → $18

Jan-10-21 03:00PM	NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2020 Business Wire
Jan-06-21 12:14PM	Nature Methods Selects Spatially-Resolved Transcriptomics as the Method of the Year for 2020 Business Wire
Jan-04-21 04:01PM	NanoString to Present at the 39th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-18-20 08:51AM	Is NSTG A Good Stock To Buy Now? Insider Monkey
Dec-09-20 06:00AM	NanoStrings GeoMx Digital Spatial Profiler Identifies Diverse Immune Responses Within COVID-19 Patients in Study Published in Nature Communications Business Wire
Dec-01-20 06:00AM	NanoString Unveils Spatial Molecular Imaging Platform, Complementing GeoMx DSP to Provide Compelling Product Roadmap for Spatial Biology Business Wire +10.05%
Nov-18-20 04:01PM	NanoString to Host Virtual Investor and Analyst Day on December 1st, 2020 Business Wire
Nov-17-20 06:00AM	NanoString and Oregon Health & Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer Business Wire +5.02%
Nov-12-20 04:01PM	NanoString to Present at the Stifel 2020 Virtual Healthcare Conference Business Wire +5.13%
06:47AM	Here's What Analysts Are Forecasting For NanoString Technologies, Inc. (NASDAQ:NSTG) After Its Third-Quarter Results Simply Wall St.
Nov-11-20 06:00AM	NanoString Highlights Growing Body of Spatial Biology Research Presented at the 35th Annual Meeting of the Society of Immunotherapy of Cancer Conference (SITC) Business Wire +12.81%
Nov-09-20 05:25PM	NanoString Technologies (NSTG) Reports Q3 Loss, Tops Revenue Estimates Zacks
05:21PM	NanoString Technologies: Q3 Earnings Insights Benzinga
04:01PM	NanoString Technologies Releases Operating Results for Third Quarter of 2020 Business Wire
06:00AM	NanoString Launches GeoMx DSP Protein Assays for Next Generation Sequencing Business Wire
Nov-06-20 04:01PM	NanoString to Present at the 29th Annual Credit Suisse Healthcare Conference Business Wire
Nov-02-20 12:31PM	Will NanoString Technologies (NSTG) Report Negative Earnings Next Week? What You Should Know Zacks
Oct-13-20 04:01PM	NanoString Technologies Announces Closing of Public Offering of $230.0 Million of Common Stock Including Exercise in Full of Option to Purchase Additional Shares Business Wire
Oct-08-20 09:33AM	OnRamp Bio and NanoString Announce Global Availability of ROSALIND® for nCounter Users Business Wire -5.20%
Oct-07-20 07:58PM	NanoString Technologies Announces Pricing of Upsized Public Offering of $200 Million of Common Stock Business Wire
Oct-06-20 04:18PM	NanoString Technologies Announces Commencement of Public Offering of Common Stock Business Wire
04:06PM	NanoString Technologies Provides Preliminary Financial and Operational Highlights for Third Quarter 2020 Business Wire
Oct-05-20 06:00AM	NanoString to Release Third Quarter 2020 Operating Results and Host Conference Call on Monday, November 9, 2020 Business Wire
Sep-14-20 06:00AM	NanoString Launches Whole Transcriptome Atlas under GeoMx Technology Access Program and Names First GeoMx Premier Access Sites Business Wire +6.51%
Sep-09-20 04:01PM	NanoString to Present at the 18th Annual Morgan Stanley Global Healthcare Conference Business Wire
09:44AM	Benzinga's Top Upgrades, Downgrades For September 9, 2020 Benzinga
06:00AM	NanoString Announces New GeoMx COVID-19 Consortium, Part of the GeoMx Translational Leadership Network Business Wire
Sep-03-20 04:01PM	NanoString to Present at the 2020 Baird Global Healthcare Conference Business Wire -7.56%
Aug-11-20 11:00AM	Is NanoString Technologies (NASDAQ:NSTG) A Risky Investment? Simply Wall St.
10:54AM	Did You Miss NanoString Technologies' (NASDAQ:NSTG) Impressive 151% Share Price Gain? Simply Wall St.
Aug-10-20 06:15PM	NanoString Technologies (NSTG) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:01PM	NanoString Technologies Releases Operating Results for Second Quarter of 2020 Business Wire
Aug-07-20 08:46AM	Medical Products Stock Earnings on Aug 10: CGC, SDGR & More Zacks
Aug-06-20 06:00AM	NanoString and Bio-Techne Announce Offering of RNAscope Reagents Validated for Use With the GeoMx Digital Spatial Profiler Business Wire
06:00AM	Bio-Techne And NanoString Announce Offering Of RNAscope Reagents Validated For Use With The GeoMx Digital Spatial Profiler PR Newswire
Aug-05-20 05:49PM	Were Hedge Funds Right About Buying NanoString Technologies Inc (NSTG)? Insider Monkey
Aug-03-20 12:31PM	Will NanoString Technologies (NSTG) Report Negative Earnings Next Week? What You Should Know Zacks
06:00AM	NanoString Extends Leadership in Spatial Genomics with Launch of GeoMx DSP Read-Out for Next Generation Sequencers Business Wire
Jul-08-20 06:00AM	NanoString to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020 Business Wire
Jul-02-20 08:39AM	NanoString Technologies (NSTG) Surges: Stock Moves 10.3% Higher Zacks +8.25%
Jun-23-20 11:06AM	Hedge Funds Getting Crazy About NanoString Technologies Inc (NSTG) Insider Monkey
Jun-17-20 05:05PM	Edited Transcript of NSTG.OQ earnings conference call or presentation 7-May-20 8:30pm GMT Thomson Reuters StreetEvents
Jun-16-20 05:41PM	NanoString Announces New Products to Advance COVID-19 Disease Research Business Wire
May-20-20 09:00AM	NanoString and OnRamp BioInformatics Partner to Develop Cloud-Based Analysis Solutions for nCounter Data Business Wire
May-19-20 09:37AM	21 Risky Stocks That Might Have Borrowed More Than Is Good For Them Barrons.com
May-14-20 04:00PM	NanoString to Present at the UBS Global Healthcare Conference Business Wire +5.23%
May-12-20 06:00AM	Recent Publications Demonstrate the Performance of the GeoMx DSP and Establish New Standards for Spatial Profiling in Discovery & Translational Research Business Wire -7.95%
May-11-20 06:00AM	NanoString to Present at the Bank of America Health Care Conference Business Wire +7.12%
May-09-20 12:01PM	Nanostring Technologies (NSTG) Q1 2020 Earnings Call Transcript Motley Fool
May-07-20 06:35PM	NanoString Technologies (NSTG) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:01PM	NanoString Technologies Releases Operating Results for First Quarter of 2020 Business Wire
Apr-15-20 09:00AM	Singapore Researchers Use NanoStrings nCounter Platform to Rapidly Profile the Response of the Immune System to the SARS-CoV-2 Virus Business Wire
Apr-07-20 06:34AM	Downgrade: Here's How Analysts See NanoString Technologies, Inc. (NASDAQ:NSTG) Performing In The Near Term Simply Wall St.
Apr-06-20 04:01PM	NanoString Provides COVID-19 Business Update and Announces Conference Call on Thursday May 7th, 2020 Business Wire +6.87%
Mar-27-20 09:47AM	Why NanoString Technologies (NSTG) Stock Might be a Great Pick Zacks -11.44%
Mar-07-20 07:05AM	Edited Transcript of NSTG earnings conference call or presentation 26-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
Mar-05-20 06:00AM	NanoString Technologies Announces Pricing of Upsized Offering of $200 Million of Convertible Senior Notes Business Wire
Mar-04-20 07:21AM	NanoString Technologies Announces Proposed Private Offering of $175 Million of Convertible Senior Notes Business Wire
Mar-03-20 09:41AM	Top Ranked Momentum Stocks to Buy for March 3rd Zacks
Mar-02-20 06:05AM	Will NanoString Technologies Continue to Surge Higher? Zacks
Feb-28-20 09:44AM	NanoString Technologies, Inc. Analysts Are Pretty Bullish On The Stock After Recent Results Simply Wall St.
Feb-26-20 04:00PM	NanoString Technologies Releases Fourth Quarter and Full Year 2019 Operating Results and Provides 2020 Financial Outlook Business Wire
Feb-20-20 06:00AM	NanoString Highlights Groundbreaking Spatial Genomics Research Using Expanding Portfolio of GeoMx High-Plex RNA Atlas Products at 2020 Advances in Genome Biology and Technology (AGBT) Conference Business Wire
Feb-19-20 12:31PM	NanoString Technologies (NSTG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Feb-18-20 06:00AM	NanoString to Present at the 40th Annual Cowen Healthcare Conference Business Wire
Feb-10-20 09:00AM	NanoString to Release Fourth Quarter and Fiscal Year 2019 Financial Results and Host Conference Call on Wednesday, February 26, 2020 Business Wire
Feb-06-20 08:00AM	Jounce Therapeutics Presents New Vopratelimab Predictive Biomarker Data Supporting Use in the Upcoming SELECT Trial at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium Annual Meeting and Announces Research Collaboration with NanoString Technologies GlobeNewswire
Jan-20-20 09:40AM	Is NanoString Technologies (NASDAQ:NSTG) Weighed On By Its Debt Load? Simply Wall St.
Jan-15-20 01:28PM	Two Landmark Nature Publications use NanoStrings GeoMx Digital Spatial Profiling to Dissect Mechanisms of Response to Immunotherapy Business Wire
Jan-12-20 06:00PM	NanoString Provides Preliminary Operational and Financial Results for Fourth Quarter and FY 2019 Business Wire
Jan-02-20 04:01PM	NanoString to Present at the 38th Annual JP Morgan Healthcare Conference Business Wire
Dec-11-19 06:00AM	NanoString Announces the Creation of the GeoMx Breast Cancer Consortium Business Wire
Dec-10-19 02:25PM	Here is What Hedge Funds Think About NanoString Technologies Inc (NSTG) Insider Monkey
Dec-06-19 12:59PM	Is NanoString Technologies, Inc.'s (NASDAQ:NSTG) CEO Paid At A Competitive Rate? Simply Wall St.
Dec-03-19 06:05PM	Peninsula diagnostics company's overseas plans could more than triple revenue American City Business Journals
05:09PM	$50M deal could expand NanoString Technologies diagnostic test into more markets American City Business Journals
05:00PM	NanoString Announces Exclusive License of nCounter Diagnostic Assets and Rights to Veracyte Business Wire
06:00AM	Nature Medicine Publication Highlights Use of NanoStrings Hyb & Seq Technology to Perform Rapid Genotypic and Phenotypic Antibiotic Susceptibility Testing Business Wire
Nov-25-19 04:01PM	NanoString to Present at the Evercore ISI 2nd Annual HealthCONx Conference TEST Business Wire Releases
04:01PM	NanoString to Present at the Evercore ISI 2nd Annual HealthCONx Conference Business Wire
Nov-20-19 05:29PM	Edited Transcript of NSTG earnings conference call or presentation 4-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-13-19 04:01PM	NanoString to Present at the Stifel 2019 Healthcare Conference Business Wire
Nov-07-19 04:01PM	NanoString Highlights the Results of Research Presented at the 2019 Annual Meeting of the Society of Immunotherapy for Cancer (SITC) Business Wire
Nov-04-19 06:15PM	NanoString Technologies (NSTG) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:01PM	NanoString Technologies Releases Operating Results for Third Quarter of 2019 Business Wire
06:00AM	NanoString Technologies Supports the Human Cell Atlas (HCA) to Enable High-plex Spatial Analysis Across Discovery Programs Business Wire
06:00AM	NanoString Announces Availability of the GeoMx Cancer Transcriptome Atlas Through the Technology Access Program for Digital Spatial Profiling Business Wire
Oct-31-19 06:00AM	NanoString Appoints Don Kania, Ph.D. to its Board of Directors Business Wire
Oct-28-19 02:57PM	Should You Avoid NanoString Technologies Inc (NSTG)? Insider Monkey
10:32AM	Analysts Estimate NanoString Technologies (NSTG) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-21-19 02:03PM	One Thing To Remember About The NanoString Technologies, Inc. (NASDAQ:NSTG) Share Price Simply Wall St.
Oct-07-19 04:05PM	NanoString to Release Third Quarter 2019 Financial Results and Host Conference Call on Monday, November 4, 2019 Business Wire
Oct-04-19 04:30PM	NanoString Reports Inducement Grant Under NASDAQ Listing Rules Business Wire
Oct-02-19 06:00AM	NanoString Appoints Mark Winham Senior Vice President of Operations Business Wire
Sep-24-19 08:00AM	CareDx Adds HistoMap To Testing Portfolio GlobeNewswire -8.47%
Sep-23-19 06:00AM	NanoString Introduces New Gene Expression Research Panel for Human Organ Transplantation Business Wire
Sep-06-19 07:15AM	The NanoString Technologies (NASDAQ:NSTG) Share Price Has Gained 87% And Shareholders Are Hoping For More Simply Wall St.
Aug-28-19 06:00AM	NanoString to Present at the 2019 Morgan Stanley Global Healthcare Conference GlobeNewswire
Aug-21-19 11:57PM	Edited Transcript of NSTG earnings conference call or presentation 31-Jul-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-19-19 06:00AM	NanoString to Present at the Baird 2019 Global Healthcare Conference GlobeNewswire

NanoString Technologies, Inc. provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; and pan cancer and 360 gene expression, CAR-T characterization, neuropathology and neuro-inflammation gene expression, autoimmune disease gene expression, miRNA expression, human organ transplant, human and mouse metabolic pathway, and human and mouse fibrosis panels. Further, the company offers nCounter based reagents that allow users to design customized assays; Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics; and Hyb & Seq molecular profiling system to determine and analyze gene sequences within biological samples. It has collaboration with Celgene Corporation; Merck & Co., Inc.; Medivation, Inc.; Astellas Pharma, Inc.; and Oregon Health & Science University for the development of novel GeoMx Digital Spatial Profiler protein assays to spatially profile breast cancer. NanoString Technologies, Inc. was founded in 2003 and is headquartered in Seattle, Washington.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Malloy Kirk	Director	Jan 11	Option Exercise	12.80	2,500	32,010	3,490	Jan 13 04:36 PM
Malloy Kirk	Director	Jan 11	Sale	66.53	2,500	166,325	990	Jan 13 04:36 PM
HERSHBERG ROBERT	Director	Dec 15	Option Exercise	11.20	1,500	16,800	3,390	Dec 16 04:17 PM
HERSHBERG ROBERT	Director	Dec 15	Sale	69.33	1,500	103,994	1,890	Dec 16 04:17 PM
Norden Gregory	Director	Dec 07	Option Exercise	1.92	10,406	19,980	12,296	Dec 09 04:41 PM
WAITE CHARLES P JR	Director	Dec 07	Option Exercise	18.88	37,860	714,711	39,750	Dec 09 04:40 PM
Norden Gregory	Director	Dec 07	Sale	58.32	10,406	606,892	1,890	Dec 09 04:41 PM
WAITE CHARLES P JR	Director	Dec 07	Sale	60.47	37,860	2,289,380	1,890	Dec 09 04:40 PM
Bailey K Thomas	Chief Financial Officer	Nov 19	Option Exercise	23.34	12,709	296,628	12,709	Nov 20 04:56 PM
Bailey K Thomas	Chief Financial Officer	Nov 19	Sale	47.35	12,709	601,729	0	Nov 20 04:56 PM
Bailey K Thomas	Chief Financial Officer	Nov 18	Option Exercise	8.16	5,937	48,446	5,937	Nov 20 04:56 PM
Bailey K Thomas	Chief Financial Officer	Nov 18	Sale	48.21	5,937	286,197	0	Nov 20 04:56 PM
HERSHBERG ROBERT	Director	Nov 16	Option Exercise	11.20	1,500	16,800	3,390	Nov 18 04:17 PM
BROWN J. CHAD	SVP, Sales & Marketing	Nov 16	Option Exercise	17.52	6,281	110,049	6,721	Nov 18 04:18 PM
HERSHBERG ROBERT	Director	Nov 16	Sale	46.67	1,500	70,002	1,890	Nov 18 04:17 PM
BROWN J. CHAD	SVP, Sales & Marketing	Nov 16	Sale	46.21	6,281	290,245	440	Nov 18 04:18 PM
Malloy Kirk	Director	Nov 09	Option Exercise	12.80	2,500	32,010	3,490	Nov 12 05:00 PM
Malloy Kirk	Director	Nov 09	Sale	40.96	2,500	102,400	990	Nov 12 05:00 PM
HERSHBERG ROBERT	Director	Oct 15	Option Exercise	11.20	1,500	16,800	3,390	Oct 16 04:44 PM
HERSHBERG ROBERT	Director	Oct 15	Sale	39.35	1,500	59,019	1,890	Oct 16 04:44 PM
HERSHBERG ROBERT	Director	Sep 15	Option Exercise	11.20	1,500	16,800	3,390	Sep 17 05:10 PM
HERSHBERG ROBERT	Director	Sep 15	Sale	43.62	1,500	65,431	1,890	Sep 17 05:10 PM
GRAY R BRADLEY	President and CEO	Sep 09	Option Exercise	1.92	37,951	72,866	149,637	Sep 11 04:41 PM
GRAY R BRADLEY	President and CEO	Sep 09	Sale	38.85	37,951	1,474,512	111,686	Sep 11 04:41 PM
Malloy Kirk	Director	Sep 08	Option Exercise	12.80	2,500	32,010	4,390	Sep 11 04:41 PM
Malloy Kirk	Director	Sep 08	Sale	36.61	3,400	124,474	990	Sep 11 04:41 PM
Bailey K Thomas	Chief Financial Officer	Aug 18	Option Exercise	8.16	5,938	48,454	5,938	Aug 20 04:46 PM
Bailey K Thomas	Chief Financial Officer	Aug 18	Sale	38.94	5,938	231,229	0	Aug 20 04:46 PM
HERSHBERG ROBERT	Director	Aug 17	Option Exercise	11.20	1,500	16,800	3,390	Aug 19 04:40 PM
HERSHBERG ROBERT	Director	Aug 17	Sale	38.37	1,500	57,555	1,890	Aug 19 04:40 PM
BROWN J. CHAD	SVP, Sales & Marketing	Aug 14	Option Exercise	17.52	6,281	110,049	6,448	Aug 18 04:32 PM
BROWN J. CHAD	SVP, Sales & Marketing	Aug 14	Sale	38.05	6,281	238,992	167	Aug 18 04:32 PM
Norden Gregory	Director	Aug 13	Sale	38.83	10,000	388,250	1,890	Aug 13 06:43 PM
Malloy Kirk	Director	Aug 11	Option Exercise	12.80	2,500	32,010	4,390	Aug 13 04:48 PM
Malloy Kirk	Director	Aug 11	Sale	35.97	2,500	89,925	1,890	Aug 13 04:48 PM
HERSHBERG ROBERT	Director	Jul 15	Option Exercise	11.20	1,500	16,800	3,390	Jul 17 04:53 PM
HERSHBERG ROBERT	Director	Jul 15	Sale	36.15	1,500	54,224	1,890	Jul 17 04:53 PM
GRAY R BRADLEY	President and CEO	Jul 06	Option Exercise	1.92	40,000	76,800	142,903	Jul 08 04:34 PM
GRAY R BRADLEY	President and CEO	Jul 06	Sale	37.03	40,000	1,481,200	102,903	Jul 08 04:34 PM
Bailey K Thomas	Chief Financial Officer	Jun 30	Sale	29.17	3,260	95,105	0	Jul 02 04:35 PM
GRAY R BRADLEY	President and CEO	Jun 19	Option Exercise	1.92	13,637	26,183	116,540	Jun 22 04:13 PM
GRAY R BRADLEY	President and CEO	Jun 19	Sale	33.58	13,637	457,930	102,903	Jun 22 04:13 PM
GRAY R BRADLEY	President and CEO	Jun 18	Option Exercise	1.92	6,363	12,217	109,266	Jun 22 04:13 PM
GRAY R BRADLEY	President and CEO	Jun 18	Sale	33.57	6,363	213,606	102,903	Jun 22 04:13 PM
HERSHBERG ROBERT	Director	Jun 15	Option Exercise	11.20	1,500	16,800	3,390	Jun 17 07:45 PM
HERSHBERG ROBERT	Director	Jun 15	Sale	30.79	1,500	46,186	1,890	Jun 17 07:45 PM
BROWN J. CHAD	SVP, Sales & Marketing	Jun 01	Option Exercise	20.45	12,635	258,351	34,879	Jun 03 04:18 PM
BROWN J. CHAD	SVP, Sales & Marketing	Jun 01	Sale	30.83	34,712	1,070,133	167	Jun 03 04:18 PM
Bailey K Thomas	Chief Financial Officer	May 18	Option Exercise	8.16	5,937	48,446	9,197	May 20 04:16 PM
Bailey K Thomas	Chief Financial Officer	May 18	Sale	31.86	5,937	189,130	3,260	May 20 04:16 PM
HERSHBERG ROBERT	Director	May 15	Option Exercise	7.47	10,168	75,955	10,168	May 18 06:13 PM
HERSHBERG ROBERT	Director	May 15	Sale	30.83	10,168	313,434	0	May 18 06:13 PM
WAITE CHARLES P JR	Director	May 14	Option Exercise	8.45	1,734	14,652	1,734	May 18 06:13 PM
WAITE CHARLES P JR	Director	May 14	Sale	30.17	1,734	52,315	0	May 18 06:13 PM
WAITE CHARLES P JR	Director	May 12	Option Exercise	8.45	6,094	51,494	6,094	May 14 04:13 PM
WAITE CHARLES P JR	Director	May 12	Sale	32.27	6,094	196,653	0	May 14 04:13 PM
Malloy Kirk	Director	Apr 20	Option Exercise	16.36	1,500	24,540	1,500	Apr 22 04:27 PM
Malloy Kirk	Director	Apr 20	Sale	30.00	1,500	45,000	0	Apr 22 04:27 PM
Malloy Kirk	Director	Apr 15	Option Exercise	7.47	1,000	7,470	1,000	Apr 17 04:12 PM
Malloy Kirk	Director	Apr 15	Sale	25.61	1,000	25,613	0	Apr 17 04:12 PM
GRAY R BRADLEY	President and CEO	Mar 16	Option Exercise	0.00	21,994	0	111,558	Mar 18 05:22 PM
GHESQUIERE DAVID W.	SVP, Corporate & Business Dev	Mar 16	Option Exercise	0.00	3,177	0	71,577	Mar 18 05:21 PM
Bailey K Thomas	Chief Financial Officer	Mar 16	Option Exercise	0.00	5,376	0	5,376	Mar 18 05:21 PM
BROWN J. CHAD	SVP, Sales & Marketing	Mar 16	Option Exercise	0.00	5,376	0	23,554	Mar 18 05:22 PM
BEECHEM JOSEPH M	SVP, Research & Development	Mar 16	Option Exercise	0.00	5,376	0	57,982	Mar 18 05:21 PM
Bailey K Thomas	Chief Financial Officer	Mar 10	Option Exercise	8.16	7,917	64,603	7,917	Mar 11 04:17 PM
Bailey K Thomas	Chief Financial Officer	Mar 10	Sale	31.47	7,917	249,185	0	Mar 11 04:17 PM
GRAY R BRADLEY	President and CEO	Mar 09	Option Exercise	2.09	42,049	87,790	98,673	Mar 11 04:18 PM
GRAY R BRADLEY	President and CEO	Mar 09	Sale	31.62	42,049	1,329,480	56,624	Mar 11 04:18 PM
GHESQUIERE DAVID W.	SVP, Corporate & Business Dev	Feb 27	Option Exercise	12.50	22,000	275,000	76,169	Mar 02 04:05 PM
GHESQUIERE DAVID W.	SVP, Corporate & Business Dev	Feb 27	Sale	35.09	22,000	771,993	54,169	Mar 02 04:05 PM
BROWN J. CHAD	SVP, Sales & Marketing	Feb 18	Option Exercise	14.98	1,458	21,842	11,713	Feb 18 05:18 PM
BROWN J. CHAD	SVP, Sales & Marketing	Feb 18	Sale	33.51	1,458	48,858	10,255	Feb 18 05:18 PM
GRAY R BRADLEY	President and CEO	Feb 14	Option Exercise	2.24	20,000	44,800	70,050	Feb 18 05:19 PM
BROWN J. CHAD	SVP, Sales & Marketing	Feb 14	Option Exercise	12.28	6,102	74,909	16,357	Feb 18 05:18 PM
BROWN J. CHAD	SVP, Sales & Marketing	Feb 14	Sale	32.00	6,102	195,264	10,255	Feb 18 05:18 PM
GRAY R BRADLEY	President and CEO	Feb 14	Sale	33.63	20,000	672,564	50,050	Feb 18 05:19 PM
BROWN J. CHAD	SVP, Sales & Marketing	Feb 13	Option Exercise	16.35	8,801	143,896	19,056	Feb 13 04:47 PM
Malloy Kirk	Director	Feb 12	Option Exercise	12.80	2,500	32,010	1,500	Feb 13 04:46 PM
Malloy Kirk	Director	Feb 12	Sale	31.18	2,500	77,950	0	Feb 13 04:46 PM
GRAY R BRADLEY	President and CEO	Feb 11	Option Exercise	2.24	20,000	44,800	70,050	Feb 13 04:47 PM
BROWN J. CHAD	SVP, Sales & Marketing	Feb 11	Option Exercise	16.35	7,700	125,895	17,955	Feb 13 04:47 PM
GRAY R BRADLEY	President and CEO	Feb 11	Sale	31.87	20,000	637,368	50,050	Feb 13 04:47 PM
BROWN J. CHAD	SVP, Sales & Marketing	Feb 11	Sale	32.00	16,501	528,032	10,255	Feb 13 04:47 PM
Bailey K Thomas	Chief Financial Officer	Feb 03	Sale	28.10	25,872	727,076	0	Feb 05 04:15 PM
GRAY R BRADLEY	President and CEO	Jan 21	Option Exercise	2.24	20,000	44,800	70,050	Jan 23 04:10 PM
GRAY R BRADLEY	President and CEO	Jan 21	Sale	29.99	20,000	599,804	50,050	Jan 23 04:10 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience